SGRY Free Cash Flow
$187.60MTTM · USD
Period ending:
SGRY FY Free Cash FlowUSD
$209.70M$0.00
2012-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
SGRY free cash flow history
Operating cash flow minus capital expenditures. The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.
| Period ending | Free Cash Flow (USD) |
|---|---|
| 195,600,000 | |
| 209,700,000 | |
| 205,000,000 | |
| 78,200,000 | |
| 29,500,000 | |
| 204,000,000 | |
| 55,900,000 | |
| 104,795,000 | |
| 91,343,000 | |
| 86,130,000 | |
| 51,042,000 | |
| 12,513,000 | |
| 44,928,000 | |
| 41,683,000 |
Compare free cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) free cash flow
- Bridgebio Pharma Inc (BBIO) free cash flow
- Brightspring Health Services Inc (BTSG) free cash flow
- Madrigal Pharmaceuticals Inc (MDGL) free cash flow
- Ensign Group Inc (ENSG) free cash flow
- Glaukos Corp (GKOS) free cash flow
- Vaxcyte Inc (PCVX) free cash flow
- Krystal Biotech Inc (KRYS) free cash flow
All SGRY financial metrics · SGRY stock overview · How to interpret financial metrics
